GH Research PLC (GHRS)
NASDAQ
GHRS price, last 12 months
Key stats
- Previous close
- $18.25
- Open
- $18.47
- Day range
- $17.08 – $19.14
- 52-week range
- $12.04 – $31.44
- Volume
- 323K
- Avg volume (20 days)
- 363.6K
- Market cap
- $1.3B
Performance
Technicals and fundamentals
About GH Research PLC
GH Research PLC is a clinical-stage biopharmaceutical company dedicated to transforming the lives of patients by developing a practice-changing treatment for depression. Its initial focus is on developing novel and proprietary mebufotenin therapies for the treatment of patients with Treatment-Resistant Depression, or TRD. Its portfolio currently includes GH001, a proprietary inhalable mebufotenin product candidate, and GH002, a proprietary intravenous mebufotenin product candidate. The group has only a single segment: Research and Development.
- Listed on
- NASDAQ
- Market cap
- $1.3B